CDC Grand Rounds: Pre-Exposure Prophylaxis for Prevention of HIV

An estimated 50,000 individuals become infected with the human immunodeficiency virus (HIV) in the United States annually. A new prevention strategy, Pre-exposure Prophylaxis (PrEP), is intended for high-risk populations to reduce their risk of becoming infected with HIV. PrEP includes daily medication and routine follow-up. When used consistently, PrEP is shown to reduce the risk of HIV infection. If delivered effectively and used in combination with other proven prevention methods, PrEP may play a significant role in helping to address the HIV epidemic in the United States.

Comments on this video are allowed in accordance with our comment policy: http://www.cdc.gov/SocialMedia/Tools/...

This video can also be viewed at
http://www.cdc.gov/cdcgrandrounds/arc...